CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Phacoemulsification with enhanced monofocal IOLsprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07439835
NCT07439835N/ACompleted
CompareCT.gov

Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens: A Prospective Study

Democritus University of Thrace·observational·Posted Feb 27, 2026·Updated Feb 27, 2026

In Brief

An observational study evaluating Phacoemulsification with enhanced monofocal IOLs for Presbyopia and IOL, Cataract. Completed, enrolled 62 participants across 1 site.

Detailed Summary

The primary objective of this study is to evaluate postoperative visual acuity curves in pseudophakic patients following unilateral or bilateral implantation of the enhanced monofocal TECNIS Eyhance IOL, using the DDARTVC.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia, IOL, Cataract
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedFeb 27, 2026
Enrollment StartApr 1, 2024
Primary CompletionJul 20, 2025
Study CompletionDec 15, 2025
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4 months ago

Interventions

Phacoemulsification with enhanced monofocal IOLsprocedure

Uneventful pseudophakic presbyopic correction with the enhanced monofocal IOL TECNIS® Eyhance ICB00 (Johnson \& Johnson Vision, USA)